- Q1 2024 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 08, 2024€12.95 (-0.77%)Earnings
- Q4 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJan 31, 2024€10.6 (-2.75%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 08, 2023€8.12 (-2.87%)Earnings
- Teva Pharmaceutical Industries Ltd to Discuss the Collaboration with Sanofi to Deliver Inflammatory Bowel Disease Treatment Call TranscriptOct 04, 2023
- Teva Pharmaceutical Industries Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 02, 2023€7.48 (-1.06%)Earnings
- Teva Pharmaceutical Industries Ltd Investor Day TranscriptMay 18, 2023
- Q1 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 10, 2023€8.26 (+0.24%)Earnings
- Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 08, 2023€9.96 (+0.40%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 03, 2022€8.9 (-1.55%)Earnings
- Q2 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 27, 2022€8.06 (+14.81%)Earnings
- Q1 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 03, 2022€8.04 (-2.90%)Earnings
- Q4 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 09, 2022€7.27 (+0.69%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptOct 27, 2021€8.01 (-7.72%)Earnings
- Q2 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 28, 2021€7.51 (-0.40%)Earnings
- Q1 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptApr 28, 2021€8.55 (-1.61%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Global High Yield & Leveraged Finance Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 10, 2021€10.54 (+1.74%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 05, 2020€7.7 (+1.58%)Earnings
- Q2 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 05, 2020€10.36 (+8.37%)Earnings
- Q1 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 07, 2020€9.75 (+4.17%)Earnings
- Q4 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 12, 2020€12.12 (+7.07%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 07, 2019€7.31 (-2.53%)Earnings
- Q2 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 07, 2019€6.32 (-6.78%)Earnings
- Q1 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 02, 2019€13.55 (-2.87%)Earnings
- Q4 2018 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 13, 2019€15.1 (-10.44%)Earnings
Q1 2024 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
Hello, and welcome to the First Quarter 2024 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today.
(Operator Instructions)
I'll now hand it over to your host, Ran Meir, Head of Investor Relations. Please go ahead.
Thank you, Alex, and thank you, everyone, for joining us today. We hope you have had a chance to review our Q1 results press release, along with the press release announcing positive Phase III results from olanzapine LAI trial, both issued earlier this morning. Copies of these press releases, along with the slides presented during this call are available on our website at ir.tevapharm.com.
Please review our forward-looking statements on Slide #2. Additional information on these statements and our non-GAAP financial measures can be found on our earnings release, annual SEC Forms, 10-K and 10-Q.
To begin today's call, Richard Francis, Teva's CEO, will provide an overview of Teva's first
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)